Incyte has entered into a $750m definitive agreement to acquire Escient Pharmaceuticals and its pipeline of small molecule ...

PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients ...

Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPT ...

If you’ve worked in pharma marketing, you’ll know how hard it can be of late. You’ll spend a load of budget on what looks and ...

Takeda and Kumquat Biosciences have entered into a collaboration agreement worth over $1.2bn to advance an oral ...

Sanofi has shared promising results from a mid-stage study of its investigational anti-CD40L antibody, frexalimab, in ...

PME spoke to Marci English, Vice President and Head of BioPharma Development, Astellas, about the importance of new ...

Researchers from the Institute of Cancer Research (ICR) have discovered a new way to convert inhibitor-style targeted cancer ...

A new UK-wide report commissioned by Bristol Myers Squibb (BMS) and Shine Cancer Support has revealed disparities in cancer ...

Center for Drug Evaluation and Research (CDER) has announced the launch of a new hub focused on promoting innovation in ...

Roche has announced positive phase 3 results for its ten-minute subcutaneous (SC) Ocrevus (ocrelizumab) injection in patients ...

Gilead Sciences has announced that the National Institute for Health and Care Excellence (NICE) has recommended Veklury ...